| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Regulatory Affairs
1 company
Peterson Caryn is an EVP, Regulatory Affairs at GOSS. Recent filings cover 0 purchases and 5 sales.
Our model assigns Peterson Caryn a middling insider score of 63/100, based on 5 past trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of +29.6%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | GOSS Gossamer Bio, Inc. | EVP, Regulatory Affairs | Sell | 4,018 | $1.33 | $5,342.73 | -7.5% | -62.3% | +2.9% | |
| Mar 16, 2023 | GOSS Gossamer Bio, Inc. | EVP, Regulatory Affairs | Sell | 7,564 | $1.10 | $8,305.27 | -12.3% | +19.0% | +39.0% | |
| Oct 24, 2022 | GOSS Gossamer Bio, Inc. | EVP, Regulatory Affairs | Sell | 4,757 | $12.07 | $57,431.26 | -7.2% | -82.6% | -96.0% | |
| Mar 16, 2022 | GOSS Gossamer Bio, Inc. | EVP, Regulatory Affairs | Sell | 6,279 | $8.28 | $51,977.56 | -8.7% | -30.5% | -87.8% | |
| Oct 25, 2021 | GOSS Gossamer Bio, Inc. | EVP, Regulatory Affairs | Sell | 2,377 | $12.25 | $29,118.25 | -3.2% | -19.3% | -6.2% |